Day One Biopharmaceuticals is a clinical-stage company that is passionate about developing and commercializing innovative targeted therapies for patients of all ages. With a strong focus on children with cancer, their mission is to support these young patients from day one and every day after. Day One Biopharmaceuticals is dedicated to bringing novel targeted therapies, particularly for childhood brain cancer, to those who can benefit from them.

They are committed to making a difference in the lives of patients and are actively working to develop medicines that have a positive impact. In addition to their development pipeline, Day One Biopharmaceuticals also offers career opportunities for individuals looking to join a team that is focused on making a difference in the field of biopharmaceuticals. They prioritize diversity and inclusion and provide benefits that matter to their employees.

For investors and media, Day One Biopharmaceuticals provides comprehensive information about their company overview, press releases, events and presentations, stock information, financials and filings, and corporate governance. Overall, Day One Biopharmaceuticals is a brand that is dedicated to developing targeted therapies and making a meaningful impact for patients, especially children with cancer